MENU
免責聲明
本網站僅提供窩客幫資訊參考平台， 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料（以下簡稱『內容』）。無論其為公開張貼或私下傳送，若有不實或違法情事，均為『內容』提供者之責任，窩客幫概不負責也不承擔任何法律責任。

豐華生物科技股份有限公司
豐華生物科技股份有限公司

Expert in probiotic and postbiotic integrated solution

Glac Biotech has been dedicated to the field of functional probiotics and postbiotics for many years.
We adhere to the business philosophy of "Science, Quality, Sincerity, and Uniqueness" and implement quality and safety guarantees throughout the entire industry chain to our business core value.
We provide customers with one-stop, vertically integrated solutions.
With our world-class fermentation production lines and patented technology, Glac provides our customers with excellent quality and exceeding value probiotic, postbiotic, concentrated fermentation liquids, agricultural and livestock probiotic ingredients and service.
Glac also offers contract manufacturing service to tailor the production conditions for customized probiotic products.

HISTORY

From Strain Database to Vertical Integration: Glac Biotech's Journey

  • 2008
    Glac Biotech was established in Taiwan and created a probiotic strain database.
  • 2010
    The probiotic screening platform technology was established and the company expanded our international business operations.
  • 2017-2018
    Glac Biotech established a plant in Chiayi, launched the PRONULIFE® brand for probiotic blend ingredients and became members of International Scientific Association for Probiotics and Prebiotics- ISAPP and International Probiotics Association- iPA.
  • 2019-2020
    Glac Biotech launched the Totipro® brand for postbiotic ingredients and our plants obtained international certificates：HACCP, ISO22000, FSSC22000, TQF, and NSF. We won The 16th National Innovation Award and TALAB Innovation Product Award, and expanded our verification to Malaysia for exports
  • 2021-2022
    The Chiayi plant introduced world-class fully automated fermentation equipment. Established the world-exclusive PRONEX® probiotic manufacturing technology and the PRIMETEK® vertical integration service for the entire industry chain. Glac also obtained the TGA medicine certificate in Australia and our Lactobacillus rhamnosus MP108 probiotic strain is the first in Taiwan to be approved by China for use in infants.
  • 2023-2024
    Glac is thrilled to expand our new plants in Hsinchu and upgrade our PRIMETEK® service.

The Leading Probiotcs and Postbiotics Contract Manufacturer

Global exclusive top technology

  • One Stop Service
  • Level Up Probiotics to the Next

Expert in probiotic integrated solutionRooted in Taiwan

Glac Biotech HQ Tainan
Glac Biotech Chayi Plant
Glac Biotech Taipei Office
Glac Biotech Tainan Office

Professional R&D Team and Strain Development Capabilities

  • Over

    50

    Master's and Ph.D. Researchers

  • Partnerships with

    26

    Academic and Industry Institutions Worldwide

  • Extensive Clinical Experience with More Than

    40

    Cases

In-house Independent Strain Database Since our establishment, we have focused on strain development, efficacy verification, and high-quality mass production as our core technologies.

Comprehensive Quality and Quality Assurance Monitoring

Full In-Process Quality Control (IPQC)
Seal Integrity and Moisture Testing
Critical Technology for CFU Count Monitoring
Water Activity Control
Harmful Bacteria Control
Professional Storage Conditions
Quality Inspection
Independent Factory with Dedicated Air Conditioning System
  • 15
    Deployment of 15 Strain Functions
  • 600,000
    600,000 Powder Sachets per Day
  • 800,000
    800,000 Capsules per Day

R&D Laboratory

Equipped with a variety of professional research and development technology platforms.

豐華生物科技股份有限公司
電話 : +886-6-589-1876 連絡人: 林榮錦 地址 : 1 F., No. 139, Sanmin St., Xinshi Dist., Tainan City 744007, Taiwan (R.O.C.) 信箱 : glac@glac.com.tw
  • 服務項目

  • 特別關鍵字